Huntingtin is a 350-kilodalton protein of unknown function that is mutated in Huntington's disease (HD), a neurodegenerative disorder. The mutant protein is presumed to acquire a toxic gain of function that is detrimental to striatal neurons in the brain. However, loss of a beneficial activity of wild-type huntingtin may also cause the death of striatal neurons. Here we demonstrate that wild-type huntingtin up-regulates transcription of brain-derived neurotrophic factor (BDNF), a pro-survival factor produced by cortical neurons that is necessary for survival of striatal neurons in the brain. We show that this beneficial activity of huntingtin is lost when the protein becomes mutated, resulting in decreased production of cortical BDNF. This leads to insufficient neurotrophic support for striatal neurons, which then die. Restoring wild-type huntingtin activity and increasing BDNF production may be therapeutic approaches for treating HD.

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease / C. Zuccato, A. Ciammola, D. Rigamonti, B.R. Leavitt, D. Goffredo, L. Conti, M.E. McDonald, R.M. Friedlander, V. Silani, M.R. Hayden, T. Timmusk, S. Sipione, E. Cattaneo. - In: SCIENCE. - ISSN 0036-8075. - 293:5529(2001), pp. 493-498. [10.1126/science.1059581]

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

C. Zuccato;V. Silani;E. Cattaneo
2001

Abstract

Huntingtin is a 350-kilodalton protein of unknown function that is mutated in Huntington's disease (HD), a neurodegenerative disorder. The mutant protein is presumed to acquire a toxic gain of function that is detrimental to striatal neurons in the brain. However, loss of a beneficial activity of wild-type huntingtin may also cause the death of striatal neurons. Here we demonstrate that wild-type huntingtin up-regulates transcription of brain-derived neurotrophic factor (BDNF), a pro-survival factor produced by cortical neurons that is necessary for survival of striatal neurons in the brain. We show that this beneficial activity of huntingtin is lost when the protein becomes mutated, resulting in decreased production of cortical BDNF. This leads to insufficient neurotrophic support for striatal neurons, which then die. Restoring wild-type huntingtin activity and increasing BDNF production may be therapeutic approaches for treating HD.
Neurotrophic factor; mouse model; cellular-localization; targeted disruption; gabaergic neurons; transgenic mice; messenger-RNA; rat-brain; in-vitro; expression
Settore MED/26 - Neurologia
Article (author)
File in questo prodotto:
File Dimensione Formato  
13 Zuccato Science 2001.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 458.53 kB
Formato Adobe PDF
458.53 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/61849
Citazioni
  • ???jsp.display-item.citation.pmc??? 414
  • Scopus 1037
  • ???jsp.display-item.citation.isi??? 957
social impact